昂立教育(600661.SH):擬出售交大昂立10.2%股份
格隆匯9月29日丨昂立教育(600661.SH)公佈,公司擬以協議轉讓的方式分別轉讓39,072,641股、40,476,450股上海交大昂立股份有限公司(“交大昂立”)股票,轉讓價格為人民幣3.8元/股。
具體為:(1)向麗水農幫生物科技有限公司或其指定主體協議轉讓39,072,641股,佔交大昂立總股本的5.01%,轉讓價格為每股3.80元人民幣;(2)向上海新誠新創健康科技發展有限公司或其指定主體轉讓40,476,450股,佔交大昂立總股本的5.19%,轉讓價格為每股3.80元人民幣;
如此次轉讓完成後,公司仍持有25,970,439股交大昂立股票,持股比例為3.33%,不再為交大昂立持股5%以上的大股東。
此次擬轉讓的交大昂立股票為公開交易的有價證券,前20個交易日股票交易均價為人民幣3.462元/股,本次協議轉讓價格為人民幣3.8元/股,溢價率約為9.7%。
此次交易金額約為人民幣3.02億元,經初步估算預計對公司產生約為2.13億元的收益(未考慮税費等,最終數據以會計師事務所出具的公司審計報吿為準)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.